423 related articles for article (PubMed ID: 12695747)
1. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
[TBL] [Abstract][Full Text] [Related]
2. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
3. The in vitro effects of niacin on platelet biomarkers in human volunteers.
Serebruany V; Malinin A; Aradi D; Kuliczkowski W; Norgard NB; Boden WE
Thromb Haemost; 2010 Aug; 104(2):311-7. PubMed ID: 20539903
[TBL] [Abstract][Full Text] [Related]
4. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.
Malinin AI; Atar D; Callahan KP; McKenzie ME; Serebruany VL
Eur J Pharmacol; 2003 Feb; 462(1-3):139-43. PubMed ID: 12591106
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirin.
Malinin AI; Callahan KP; Serebruany VL
Thromb Res; 2001 Nov; 104(4):297-9. PubMed ID: 11728532
[TBL] [Abstract][Full Text] [Related]
6. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
8. Effects of in vitro exposure of alcohol on surface receptor expression of human platelets.
McKenzie ME; Bell CR; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Clin Physiol Funct Imaging; 2002 Mar; 22(2):153-6. PubMed ID: 12005158
[TBL] [Abstract][Full Text] [Related]
9. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
[TBL] [Abstract][Full Text] [Related]
10. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets.
Simák J; Holada K; Janota J; Stranák Z
Pediatr Res; 1999 Oct; 46(4):445-9. PubMed ID: 10509366
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia.
Le Guyader A; Pacheco G; Seaver N; Davis-Gorman G; Copeland J; McDonagh PF
J Diabetes Complications; 2009; 23(1):65-70. PubMed ID: 18413191
[TBL] [Abstract][Full Text] [Related]
12. Uniform platelet activation exists before coronary stent implantation despite aspirin therapy.
Serebruany VL; Cummings CC; Malinin AI; Steinhubl SR; Gurbel PA
Am Heart J; 2001 Oct; 142(4):611-6. PubMed ID: 11579350
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of desflurane and sevoflurane on the expression of platelet surface glycoproteins in unstimulated and adenosine diphosphate-induced platelets in vitro.
Koroglu A; Cicek M; Toprak HI; Karakoc Y; Noyan F; Ersoy OM
J Clin Anesth; 2007 Aug; 19(5):328-33. PubMed ID: 17869981
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
Ito H; Miyakoda G; Mori T
Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
[TBL] [Abstract][Full Text] [Related]
16. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
17. [Expression patterns of platelet membrane glycoprotein in healthy adults].
Huang F; Liu R; Liu L
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
[TBL] [Abstract][Full Text] [Related]
18. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
[TBL] [Abstract][Full Text] [Related]
19. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
Serebruany VL; Malinin AI; O'connor CM; Gurbel PA;
Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
Ozsavci D; Yardimci T; Demirel GY; Demiralp E; Uras F; Onder E
Platelets; 2002 Jun; 13(4):223-9. PubMed ID: 12189024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]